Here are the latest quarterly results of the stocks in the . For more detailed updates, check the latest stock quotes.
Click on title to sort | Jun 2020 | Jun 2021 | YoY %-Change | Get More Info | ||||
---|---|---|---|---|---|---|---|---|
Name | Net Sales (Rs m) |
PAT (Rs m) |
Net Sales (Rs m) |
PAT (Rs m) |
Net Sales (%) |
PAT (%) |
P/E* (x) |
|
AUROBINDO PHARMA | 59,248 | 7,952 | 57,020 | 7,790 | -3.8% | -2.0% | 15.3 | More Info
|
AUROBINDO PHARMA | 59,248 | 7,952 | 57,020 | 7,790 | -3.8% | -2.0% | 15.3 | More Info
|
AUROBINDO PHARMA | 59,248 | 7,952 | 57,020 | 7,790 | -3.8% | -2.0% | 15.3 | More Info
|
AUROBINDO PHARMA | 59,248 | 7,952 | 57,020 | 7,790 | -3.8% | -2.0% | 15.3 | More Info
|
BIOCON | 16,938 | 1,714 | 17,606 | 1,645 | 3.9% | -4.0% | 29.4 | More Info
|
BIOCON | 16,938 | 1,714 | 17,606 | 1,645 | 3.9% | -4.0% | 29.4 | More Info
|
CIPLA | 43,462 | 5,714 | 55,044 | 7,118 | 26.6% | 24.6% | 15.2 | More Info
|
CIPLA | 43,462 | 5,714 | 55,044 | 7,118 | 26.6% | 24.6% | 15.2 | More Info
|
CIPLA | 43,462 | 5,714 | 55,044 | 7,118 | 26.6% | 24.6% | 15.2 | More Info
|
DIVIS LABORATORIES | 17,305 | 4,921 | 19,606 | 5,571 | 13.3% | 13.2% | 53.8 | More Info
|
DIVIS LABORATORIES | 17,305 | 4,921 | 19,606 | 5,571 | 13.3% | 13.2% | 53.8 | More Info
|
GLENMARK PHARMA | 23,448 | 2,540 | 29,649 | 3,065 | 26.4% | 20.7% | N.A. | More Info
|
LUPIN | 35,279 | 1,081 | 42,702 | 5,480 | 21.0% | 406.8% | 18.4 | More Info
|
LUPIN | 35,279 | 1,081 | 42,702 | 5,480 | 21.0% | 406.8% | 18.4 | More Info
|
LUPIN | 35,279 | 1,081 | 42,702 | 5,480 | 21.0% | 406.8% | 18.4 | More Info
|
PIRAMAL ENTERPRISES | 29,373 | 4,606 | 29,087 | 3,685 | -1.0% | -20.0% | N.A. | More Info
|
SUN PHARMA | 75,853 | -24,298 | 97,187 | 14,087 | 28.1% | N.A. | 13.0 | More Info
|
SUN PHARMA | 75,853 | -24,298 | 97,187 | 14,087 | 28.1% | N.A. | 13.0 | More Info
|
ZYDUS LIFESCIENCES | 35,146 | 4,543 | 40,018 | 6,455 | 13.9% | 42.1% | 11.4 | More Info
|
ZYDUS LIFESCIENCES | 35,146 | 4,543 | 40,018 | 6,455 | 13.9% | 42.1% | 11.4 | More Info
|
Sector Aggregate | 816,515 | 33,099 | 928,887 | 131,218 | 13.8% | 296.4% | ||
* Trailing 12 months earnings, excluding extraordinary / exceptional items. |
Mar 2021 Results | Sep 2021 Results | Latest Quarter Results | View All Results |